Abstract | PURPOSE: To evaluate the protective effect on corneal endothelial cells of a low-cost and an expensive combination of a dispersive viscoelastic material and an irrigating solution during phacoemulsification. SETTING: Department of Ophthalmology, University of Vienna, Vienna, Austria. METHODS: RESULTS: The acute postoperative increase in CT was +9.8 microm in the low-cost group and +10.9 microm in the expensive group; the difference between groups was not significant. After 1 month, the CT still differed significantly from baseline in the low-cost group. Three months after surgery, the CT had returned to baseline values in both groups. There was no significant between-group difference in endothelial cell counts or morphology. CONCLUSIONS:
|
Authors | Barbara Kiss, Oliver Findl, Rupert Menapace, Vanessa Petternel, Matthias Wirtitsch, Thomas Lorang, Manfred Gengler, Wolfgang Drexler |
Journal | Journal of cataract and refractive surgery
(J Cataract Refract Surg)
Vol. 29
Issue 4
Pg. 733-40
(Apr 2003)
ISSN: 0886-3350 [Print] United States |
PMID | 12686241
(Publication Type: Clinical Trial, Comparative Study, Evaluation Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Bicarbonates
- Drug Combinations
- Isotonic Solutions
- Ophthalmic Solutions
- chondroitin sulfate, sodium hyaluronate drug combination
- glutathione-bicarbonate-Ringer solution
- Hypromellose Derivatives
- Ringer's Solution
- Hyaluronic Acid
- Methylcellulose
- Chondroitin
- Chondroitin Sulfates
- Glutathione
|
Topics |
- Aged
- Aged, 80 and over
- Bicarbonates
(economics, therapeutic use)
- Cell Count
- Chondroitin
(economics, therapeutic use)
- Chondroitin Sulfates
- Corneal Edema
(economics, etiology, prevention & control)
- Cytoprotection
(drug effects)
- Double-Blind Method
- Drug Combinations
- Drug Costs
- Drug Therapy, Combination
- Endothelium, Corneal
(drug effects, pathology)
- Glutathione
(economics, therapeutic use)
- Humans
- Hyaluronic Acid
(economics, therapeutic use)
- Hypromellose Derivatives
- Isotonic Solutions
(economics, therapeutic use)
- Methylcellulose
(analogs & derivatives, economics, therapeutic use)
- Middle Aged
- Ophthalmic Solutions
(economics, therapeutic use)
- Phacoemulsification
(adverse effects, economics)
- Prospective Studies
- Ringer's Solution
|